Overexpression of a transcription factor EB (TFEB) that drives autophagy-lysosomal biogenesis in macrophages can reduce arteries atherosclerosis [77], help reduce lipid-mediated lysosomal dysfunction, increase cholesterol efflux and inactivate inflammasome activation [78]. The gene discussed is TFEB; the disease is atherosclerosis.